KRAS and lung carcinoma: Recent findings from studies in lung cancer cell lines and mouse models further elucidate this mechanism, demonstrating that the KRAS-ERK1/2-SET1A-YAP axis is central to FGL1 upregulation and the resulting immune escape phenotype (110).